Preview

Journal Infectology

Advanced search

Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis

Abstract

Literature analysis of published data on mechanisms of infection, disease progression and treatment of chronic hepatitis C, associated with systemic cryoglobulinemic vasculitis and kidney involvement is presented. A clinical case of effective treatment of cryoglobulinemic vasculitis associated with HCV infection is described. Female with HCV infection genotype 1b with liver fibrosis 1 grade Metavir developed clinical picture of essential mixed cryoglobulinemia II type with monoclonal IgM/kappa production. Cryoglobulinemia was presented with skin hemorrhagic vasculitis, proliferative vasculitis of small liver vessels, kidney involvement with III type membranoproliferative glomerulonephritis. Treatment with Dasabuvir;Оmbitasvir+Paritaprevir+Ritonavir without immunosuppressive medications or steroids resulted in persistent virologic response by 12 weeks after administration and also dramatic reduction of cryoglobulimenia from 27% to 8%, suppression of detectable IgM/kappa production, diminished skin vasculitis, restoration of glomerular filtration rate, proteinuria and decrease in erythrocyteuria.

About the Authors

N. V. Dunaeva
Centers for AIDS and Other Infectious Diseases
Russian Federation
Saint-Petersburg


V. E. Karev
Science Research Institute of Children’s Infections
Russian Federation
Saint-Petersburg


O. A. Vorobyeva
National Center of Clinical Morphological Diagnostics
Russian Federation
Saint-Petersburg


A. V. Mazing
First Saint-Petersburg State Medical University named after I.P. Pavlov
Russian Federation
Saint-Petersburg


S. V. Lapin
First Saint-Petersburg State Medical University named after I.P. Pavlov
Russian Federation
Saint-Petersburg


A. V. Smirnov
Novgorod State University named after Yaroslav-the-Wise
Russian Federation
Veliky Novgorod


D. A. Gusev
Centers for AIDS and Other Infectious Diseases
Russian Federation
Saint-Petersburg


References

1. Ignatova T.M., Aprosina Z.G., Serov V.V., Mukhin N.A., Krel P.Ye., Semenkova E.N., Popova I.V., Tanashchuk E.L. // Ther. Arhiv. 1998; 11: 9-16 (in Russian).

2. Brady HR., Wilcox CS. Therapy in nephrology and hypertension: a companion to Brenner and Rector’s The kidney. USA: W.B. Saunders Company; с.1999. Chapter 18, Cryoglobulinemia; р.125-129.

3. Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR, Efremov DG Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/ VLkv325 immunoglobulin gene combination in hepatitis C virus – associated immunocytomas. Blood. 1998 Apr.1; 91(7):2433-42.

4. Dunaeva N.V., Esaulenko E.V. Jurnal Infektologii. 2011; 3(2): 15-20 (in Russian).

5. Konstantinova N.A. Cryoglobulins and pathology. Moscow: Medicina; 1999 (in Russian).

6. Sansonno D, Tucci FA, Ghebrehiwet B, Lauletta G, Peerschke EI, Conteduca V, Russi S, Gatti P, Sansonno L, Dammacco F. Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage. J Immunol. 2009 Nov 1; 183(9): 6013-20.

7. Sansonno D, Carbone A, De Re V, Dammacco F. Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford). 2007 Apr; 46(4): 572-8.

8. Smirnov A.V., Dobronravov V.A., Sipovskii V.G., Trofimenko I.I., Pirozhkov I.A., Kayukov I.G., Lebedev K.I. Nephrologiya. 2014; 18(6): 82-93 (in Russian).

9. Milovanova S.Yu., Kozlovskaya L.V., Gordovskaya N.B. Almanach klinicheskoy medicini. 2014; 30: 46-51 (in Russian).

10. Dunaeva N.V., Nikitina O.E., Stukov B.V., Karev V.E., Mazing A.V., Lerner M.Yu., Lapin S.V., Totolyan Areg A. Infekcia i immunitet. 2014; 4(3): 284–292 (in Russian).

11. Wong W, Denton M, Rennke HG, Lin J. Hepatitis C, proteinuria and renal insufficiency. Am. J. of Kidney Dis. 2004 Nov; 44(5): 924-9.

12. Milovanova S.Yu., Lopatkina T.N., Kozlovskaya L.V., Krasnova T.N. Ther. Arhiv. 2007; 6: 69-72.

13. Smirnov A.V., Dobronravov V.A., Sipovskii V.G., Titova V.A., Klemina I.K. Nephrologiya. 2007; 11(4): 99-103 (in Russian).

14. Dunaeva N.V. Protivovirusnaya terapiya hronicheskogo gepatita C, oslozhnyennogo rasvitiem crioglobulinemii s porazheniem pochek (klinicheskie primery) [Antiviral therapy of chronic hepatitis C, complicated by the development of cryoglobulinemia with renal impairment (clinical examples). In: Materialy 10 yubileynoy Rossiisko- Italianskoy konferenzii «Aktualnye voprosy socialno-znachimyh infekcy» [Topical issues of socially significant infections: proceedings of the 10th anniversary of the Russian-Italian conference]; Velikiy Novgorod; 2011. P. 87-94. (in Russian).

15. Dobronravov V.A., Dunaeva N.V. Nephrologiya. 2008; 12(4): 9-19.

16. Kozlovskaya L.V., Mukhin N.A., Gordovskaya N.B., Konstantinova N.A., Mukhin Ya.A., Malyshko Ye.Yu. Klin. Medicina. 2001; 4: 32–35 (in Russian).

17. Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G, Confalonieri R, Tarantino A, Pasquali S, Amoroso A, Savoldi S, Colombo V, Manno C, Ponzetto A, Moriconi L, Pani A, Rustichelli R, Di Belgiojoso GB, Comotti C, Quarenghi MI. Multicenter study on hepatitis C virus related cryoglobulinemic glomerulonephritis. Am. J. Kidney Dis. 2007 Jan; 49(1): 69-82.

18. Alric L, Plaisier E, Thébault S, Péron JM, Rostaing L, Pourrat J, Ronco P, Piette JC, Cacoub P. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am. J. of Kidney Dis. 2004 Apr; 43(4): 617-23.

19. EASL Recommendations on Treatment of Hepatitis C 2015. European Association for the Study of the Liver. J. of Hepatology. 2015 Jul; 63(1): 199-236.


Review

For citations:


Dunaeva N.V., Karev V.E., Vorobyeva O.A., Mazing A.V., Lapin S.V., Smirnov A.V., Gusev D.A. Antiviral therapy of chronic hepatitis C complicated by systemic cryoglobulinemic vasculitis. Journal Infectology. 2016;8(2):40-47. (In Russ.)

Views: 688


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-6732 (Print)